Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Phase 1/2 Multicenter Randomized Trial of Local Ablation plus Toripalimab versus Toripalimab Alone for Previously Treated Unresectable Hepatocellular Carcinoma
Chunhui Zhou, Yan Li, Jiaping Li, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 15, pp. 2816-2825
Open Access | Times Cited: 15

Showing 15 citing articles:

Combination locoregional and systemic therapies in hepatocellular carcinoma
Bin‐Yan Zhong, Wenzhe Fan, Justin J. Guan, et al.
˜The œLancet. Gastroenterology & hepatology (2025)
Closed Access | Times Cited: 2
Irreversible electroporation combined with PD-L1/IL-6 dual blockade promotes anti-tumor immunity via cDC2/CD4+T cell axis in MHC-I deficient pancreatic cancer
Zhuozhuo Wu, Qungang Shan, Yuyue Jiang, et al.
Cancer Letters (2025), pp. 217620-217620
Closed Access | Times Cited: 1
Microwave ablation combined with PD‐L1 blockade synergistically promotes Cxcl9‐mediated antitumor immunity
Ningning He, Hao Huang, Shaoxian Wu, et al.
Cancer Science (2024) Vol. 115, Iss. 7, pp. 2196-2208
Open Access | Times Cited: 8
Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives
Jian‐Jian Chen, Zhi‐Cheng Jin, Bin‐Yan Zhong, et al.
United European Gastroenterology Journal (2024) Vol. 12, Iss. 2, pp. 226-239
Open Access | Times Cited: 6
T lymphocyte-based immune response and therapy in hepatocellular carcinoma: focus on TILs and CAR-T cells
Thikra Majid Muhammed, Saade Abdalkareem Jasim, Ahmed Hussein Zwamel, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma
Tong Liu, Guorui Meng, Shihui Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
The efficacy and safety of Radiofrequency ablation combined with Lenvatinib plus Sintilimab in Unresectable Hepatocellular Carcinoma: a real-world study
Xi‐Shu Wang, Ximin Sun, Yongrong Lei, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Safety and Feasibility of Combining On-Demand Selective Locoregional Treatment with First-Line Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma
Tasuku Nakabori, Sena Higashi, Yutaro Abe, et al.
Current Oncology (2024) Vol. 31, Iss. 3, pp. 1543-1555
Open Access | Times Cited: 2
Contribution of immune cells in synergistic anti-tumor effect of ablation and immunotherapy
Ningning He, Jingting Jiang
Translational Oncology (2023) Vol. 40, pp. 101859-101859
Open Access | Times Cited: 4
Advancements in second-line treatment research for hepatocellular carcinoma
Ruirui Sun, Chenrui Wu, Yang Gou, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 1
Identification of proliferative hepatocellular carcinoma using the SMARS score and implications for microwave ablation
Peng Zhou, Yan Bao, De‐Hua Chang, et al.
Insights into Imaging (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Irreversible Electroporation Combined with PD-L1/IL-6 Dual Blockade Promotes Anti-Tumor Immunity via cDC2/CD4 T Cell Axis in MHC-I Deficient Pancreatic Cancer
Zhuozhuo Wu, Qungang Shan, Yuyue Jiang, et al.
(2024)
Closed Access
Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy with Cryoablation in the First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC): a pilot study protocol for a single center, single arm, phase II study (Preprint)
Zhiqiang Gao, Jiajun Teng, Rong Qiao, et al.
(2024)
Closed Access
Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy with Cryoablation in the First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC): a pilot study protocol for a single center, single arm, phase II study (Preprint)
Zhiqiang Gao, Jiajun Teng, Rong Qiao, et al.
JMIR Research Protocols (2024) Vol. 13, pp. e64950-e64950
Open Access
Immunometabolic Targets in CD8+ T Cells within the Tumor Microenvironment of Hepatocellular Carcinoma
Yu‐Hsuan Lin, Rexiati Ruze, Ruiqing Zhang, et al.
Liver Cancer (2024), pp. 1-30
Open Access
Page 1

Scroll to top